These data also suggest that manipulation of tryptophan catabolism, AhR signaling, or IL-22 production during disease both locally (intestinal) or distally (lungs) should be further explored as novel therapeutic approaches for the prevention of alcohol-associated pneumonia. The gene discussed is AHR; the disease is susceptibility to pneumonia measurement.